Related Experiment Videos
[Chronic diffuse interstitial pneumonia associated with chronic active hepatitis. 2 cases]
D Sadoun1, M Kambouchner, Z Amoura
1Service de Pneumologie, Hôpital Avicenne, Bobigny.
Presse Medicale (Paris, France : 1983)
|November 13, 1993
Summary
Chronic active hepatitis and interstitial pneumonia may share a common immune cause. Corticosteroid therapy showed parallel improvements, suggesting a linked dysimmune pathogenesis in these liver and lung diseases.
Area of Science:
- Immunology
- Hepatology
- Pulmonology
Background:
- Chronic active hepatitis is an inflammatory liver condition.
- Diffuse interstitial pneumonia affects the lung interstitium.
- Dysimmune pathogenesis involves immune system dysregulation.
Observation:
- Two patients presented with chronic active hepatitis and diffuse interstitial pneumonia.
- Histopathology revealed lymphoid and fibrosing interstitial changes in the lungs.
- Pulmonary and hepatic symptoms evolved concurrently during corticosteroid treatment.
Findings:
- The parallel clinical course suggests a shared dysimmune pathogenesis between hepatitis and pneumonia.
- Histopathological data supports a common immune-mediated origin for both conditions.
- Literature review identified similar cases, reinforcing the link.
Implications:
- These findings suggest an immune-mediated etiology for a subset of patients with co-occurring hepatitis and interstitial pneumonia.
- Further research into immune pathways may reveal novel therapeutic targets.
- Understanding this link can improve diagnosis and management of complex autoimmune diseases.